首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Clinical Medicine Insights-oncology

Clinical Medicine Insights-oncology杂志,由Libertas Academica出版,于2010年创刊,1 issue/year,出版语言English,ISSN:1179-5549,E-ISSN:1179-5549。

投稿咨询
Clinical Medicine Insights-oncology
Clinical Medicine Insights-oncology
Clinical Medicine Insights-oncology
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
4区
影响因子
2.6
CiteScore
3.5
期刊收录
SCI、SCIE

Clinical Medicine Insights-oncology(中文译名:《临床医学洞察-肿瘤学》),ISSN:1179-5549,EISSN:1179-5549,是Libertas Academica出版的国际性学术期刊,创刊于2010年,以1 issue/year形式稳定发行,2026年总发文量约62篇。该刊采用OA开放访问,学科归属为Medicine - Oncology。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.6,2025年期刊CiteScore为3.5,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Clinical Medicine Insights-oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期8 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、Italy、Japan、France、Australia、Canada等为核心发文国家与地区;STATE UNIVERSITY SYSTEM OF FLORIDAUNICANCER、NATL HOSP ORG、UNIVERSITY OF TEXAS SYSTEM、3D MED INC、AIN SHAMS UNIVERSITY、ARMY MEDICAL UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 196 / 333

41.3

学科:ONCOLOGY SCIE Q4 253 / 333

24.17

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 234 / 322

27.5

学科:ONCOLOGY SCIE Q4 258 / 322

20.03


中国学者近期发文

1
Osimertinib for Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Current Evidenc

Author:Tang, Xiumei; Chen, Yanmei; Zhu, Yuan; Liu, Yuan; Li, Weimin; Wang, Wenzhao; Wang, Zhoufeng

Journal: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/11795549261434260

2
A Clinicopathology and Simplified Molecular Marker-Based Risk Stratification Model for Predicting 3-Year Recurrence in Endometrial Cance

Author:Zhang, Juntao; Zhou, Yichuan; Huang, Yuzhen; Qin, Xiaoyan; Yang, Hua; Yang, Chunrun; Guo, Jianbin

Journal: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/11795549261428372

3
Retrospective Analysis of the Clinical Efficacy, Safety, and Influencing Factors of Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Hepatic Malignancie

Author:Liu, Li; Sheng, Yuling; Liang, Xianxian; Yang, Tao; Dong, Li; Gao, Dazhi; Chen, Bo; Xu, Tantan; Ai, Min; Shan, Husheng; Tang, Jinjing; Zhang, Longjiang; Shi, Donghong; Zhu, Xiaoli

Journal: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/11795549261434259

4
Beta-Blocker Use and Survival Outcomes in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysi

Author:Li, Rui; Chen, Jie; Chen, Yingkai; Jin, Kai; Chen, Yong; Deng, Changyu; Liu, Xuefen; Li, Yue

Journal: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/11795549251411762

5
Effectiveness and Safety of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter, Retrospective Real-World Study in Chin

Author:Shao, Minghua; Tan, Binbin; Fan, Chao; Fu, Ying; Chen, Hailei; Liu, Ping; Zhang, Hui

Journal: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/11795549251414656

6
Clinical Analysis of Peripheral Blood Indicators for Immune-Related Adverse Events (irAEs) in Patients With Advanced Lung Cance

Author:Ji, Yin-Min; Qin, Yu-hui; Lv, Ya-Hui; Xiao, Shu-Yan; Dong, Yi; Hu, Zhi-Song; Cui, Peng-Fei; Li, Tao; Cui, Xiao-Ran; Hu, Yi

Journal: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/11795549251413304

7
Development of Nomogram for Predicting Postoperative Progression Risk in High-Risk Thymoma and Thymic Carcinoma Utilizing Clinical and Preoperative CT Feature

Author:Meng, Qian; Jiang, Nan; Chen, Jun; Weng, Chunjiao; Miao, Huanmin; Ping, Xiaoxia; Hu, Chunhong

Journal: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/11795549251413298

8
Bevacizumab Plus EGFR-TKIs vs EGFR-TKIs Alone for Advanced EGFR-Mutant NSCLC: A Meta-Analysi

Author:Wang, Zexian; Guo, Yaru; Qin, Xiaohan; Wan, Zhiling; Wu, Xiaojin; Liu, Chen

Journal: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/11795549251414657

9
Causal Association Between Lung Cancer and Rash: A Bidirectional Mendelian Randomization Stud

Author:Xiao, Yang; Li, Tian-Tian; Yuan, Ming Li; Yin, Wen; Zhu, Jing

Journal: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 2025; Vol. 19, Issue , pp. -. DOI: 10.1177/11795549251341559

10
Antibiotic Usage During Surgery may be Correlated With Survival in Radically Resected Non-Small-Cell Lung Cancer Patient

Author:Ye, Qianwen; Liu, Long; Cui, Meiqi; Liu, Mingjuan; Yan, Bing

Journal: CLINICAL MEDICINE INSIGHTS-ONCOLOGY. 2025; Vol. 19, Issue , pp. -. DOI: 10.1177/11795549251348376


在线咨询

Clinical Medicine Insights-oncology

国际简称:CLIN MED INSIGHTS-ON参考译名:临床医学洞察-肿瘤学

年发文量:62 CiteScore:3.5 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:82.26%

杂志社联系方式:1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP

Clinical Medicine Insights-oncology